Price loading...

The 2016-2021 World Outlook for Non-Small Cell Lung Cancer Therapeutics

Price data last checked 105 day(s) ago - refreshing...

View at Amazon

Price History & Forecast

No Price Data Available

Price history will appear here once data is collected from Amazon.

Price Distribution

No price data available for histogram

Product Specifications

Format
paperback
Domain
Amazon UK
Release Date
20 April 2015
Listed Since
23 April 2015

Similar Products You Might Like

The 2016-2021 Outlook for Non-Small Cell Lung Cancer Therapeutics in the United States
99% match

The 2016-2021 Outlook for Non-Small Cell Lung Cancer Therapeutics in the United States

£595.00 12 Jan 2026
The 2021-2026 World Outlook for Lung Cancer Therapeutics
98% match

The 2021-2026 World Outlook for Lung Cancer Therapeutics

£795.00 12 Jan 2026
The 2016-2021 Outlook for Non-Small Cell Lung Cancer Therapeutics in Greater China
98% match

The 2016-2021 Outlook for Non-Small Cell Lung Cancer Therapeutics in Greater China

£595.00 10 Mar 2026
The 2021-2026 World Outlook for Silent Cancer Therapeutics
97% match

The 2021-2026 World Outlook for Silent Cancer Therapeutics

£795.00 08 Jan 2026
The 2016-2021 Outlook for Pancreatic Cancer Drugs in the United States
96% match

The 2016-2021 Outlook for Pancreatic Cancer Drugs in the United States

£595.00 25 Jan 2026
The 2021-2026 World Outlook for Pancreatic Cancer Drugs
96% match

The 2021-2026 World Outlook for Pancreatic Cancer Drugs

£795.00 12 Jan 2026
The 2021-2026 World Outlook for Circulating Tumor Cell (CTC) Technologies
96% match

The 2021-2026 World Outlook for Circulating Tumor Cell (CTC) Technologies

£795.00 13 Dec 2025
The 2025-2030 World Outlook for Non-Small Cell Lung Cancers
96% match

The 2025-2030 World Outlook for Non-Small Cell Lung Cancers

£790.00 22 Jan 2026
The 2016-2021 Outlook for Liver Cancer Drugs in the United States
96% match

The 2016-2021 Outlook for Liver Cancer Drugs in the United States

£595.00 11 Jan 2026
The 2011-2016 Outlook for Non-Small Cell Lung Cancer Therapeutics in Africa, Europe & the Middle East
96% match

The 2011-2016 Outlook for Non-Small Cell Lung Cancer Therapeutics in Africa, Europe & the Middle East

£325.00 13 Dec 2025
The 2021-2026 World Outlook for Cancer Biomarkers
96% match

The 2021-2026 World Outlook for Cancer Biomarkers

£795.00 23 Jan 2026
The 2016-2021 Outlook for Hematology and Oncology Products in the United States
96% match

The 2016-2021 Outlook for Hematology and Oncology Products in the United States

£595.00 28 Feb 2026
The 2021-2026 World Outlook for Hematology and Oncology Products
96% match

The 2021-2026 World Outlook for Hematology and Oncology Products

£795.00 14 Jan 2026
The 2016-2021 Outlook for Prostate Cancer Therapeutics in Japan
96% match

The 2016-2021 Outlook for Prostate Cancer Therapeutics in Japan

£595.00 08 Mar 2026
The 2016-2021 Outlook for Bladder Cancer Therapeutics in Japan
96% match

The 2016-2021 Outlook for Bladder Cancer Therapeutics in Japan

£595.00 01 Feb 2026
The 2021-2026 World Outlook for Circulating Tumor Cells (CTC) Diagnostics
96% match

The 2021-2026 World Outlook for Circulating Tumor Cells (CTC) Diagnostics

£795.00 13 Dec 2025
The 2016-2021 World Outlook for Anti-Neoplastic Radioactive Isotopes for Internal Pharmaceutical Use
96% match

The 2016-2021 World Outlook for Anti-Neoplastic Radioactive Isotopes for Internal Pharmaceutical Use

£995.00 28 Jan 2026
The 2016-2021 Outlook for Hematology and Oncology Products in India
96% match

The 2016-2021 Outlook for Hematology and Oncology Products in India

£595.00 24 Jan 2026
The 2021-2026 World Outlook for Stem Cell Therapies
96% match

The 2021-2026 World Outlook for Stem Cell Therapies

£795.00 13 Jan 2026
The 2016-2021 Outlook for Multiple Sclerosis Therapeutics in the United States
95% match

The 2016-2021 Outlook for Multiple Sclerosis Therapeutics in the United States

£595.00 14 Jan 2026
The 2026-2031 World Outlook for Chemotherapy and Antibody Combination Antibody Therapies
95% match

The 2026-2031 World Outlook for Chemotherapy and Antibody Combination Antibody Therapies

£885.00 11 Jan 2026
The 2016-2021 Outlook for Cancer Therapies in Oceana
95% match

The 2016-2021 Outlook for Cancer Therapies in Oceana

£425.00 28 Jan 2026
The 2016-2021 Outlook for Cancer Therapies in North America & the Caribbean
95% match

The 2016-2021 Outlook for Cancer Therapies in North America & the Caribbean

£425.00 25 Jan 2026
The 2016-2021 Outlook for Cancer Therapies in Asia
95% match

The 2016-2021 Outlook for Cancer Therapies in Asia

£425.00 24 Jan 2026